MedTrace Logo

The Multicentic Trial in Fertility-sparing Treatment and Ovarian Preservation Management for Early Endometrial Cancer

NCT03804463 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 170

Last updated 2019-01-15

No results posted yet for this study

Summary

Through multicenter, prospective, randomized, controlled clinical studies comparing different treatment options (fertility-sparing surgery and ovarian preservation surgery and radical surgery)therapeutic efficacy, safety and quality of life of patients, exploration of the best strategies and risks for the treatment of early endometrial cancer, and promotion and application.

Conditions

Interventions

PROCEDURE

endometrial cancer radical surgery

Take hysterectomy and bilateral adnexectomy.

PROCEDURE

fertility-sparing surgery

Take endometrectomy , preserve uterus and bilateral ovaries.

PROCEDURE

ovarian preservation surgery

Take hysterectomy,preserve bilateral ovaries.

Sponsors & Collaborators

  • First Hospital of China Medical University

    collaborator OTHER

  • Min Wang

    lead OTHER

Principal Investigators

  • Min Wang, PHD. · Shengjing Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-10
Primary Completion
2020-12-31
Completion
2021-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03804463 on ClinicalTrials.gov